LONGMONT, Colo.--(BUSINESS WIRE)--Chemizon Inc. (KOSDAQ: 010170) announced today that CrystalGenomics (CG) has chosen Chemizon as its process chemistry partner to reengineer certain early stage routes, making them conducive for scale up. As part of this program, Chemizon’s scientists will develop and optimize new synthetic routes that are designed to reduce CG’s overall manufacturing costs and accelerate their development timelines.
